Fig. 3: Objectives responses according to RECIST 1.1. criteria. | BJC Reports

Fig. 3: Objectives responses according to RECIST 1.1. criteria.

From: A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers

Fig. 3

a Best radiological response observed to treatment as per cohort. b Spider plot of radiological response. Tumour responses were measured and values show percent change of the sum of target lesion diameters from the baseline measurements of each measurable tumour. Changes in target tumour diameter for patients included in cohort 1, cohort 2, cohort 3 and cohort 4 are represented in blue, green, yellow and red respectively.

Back to article page